^Siekierka JJ, Hung SH, Poe M, Lin CS, Sigal NH (October 1989). “A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin”. Nature341 (6244): 755–7. doi:10.1038/341755a0. PMID2477714.
^Balbach J, Schmid FX (2000). “Proline isomerization and its catalysis in protein folding”. In Pain RH. Mechanisms of protein folding (2nd ed.). Oxford: Oxford University Press. pp. 212–237. ISBN0-19-963789-X
^Wang T, Donahoe PK, Zervos AS (July 1994). “Specific interaction of type I receptors of the TGF-beta family with the immunophilin FKBP-12”. サイエンス265 (5172): 674–6. doi:10.1126/science.7518616. PMID7518616.
^Mayer AD, Dmitrewski J, Squifflet JP, Besse T, Grabensee B, Klein B, Eigler FW, Heemann U, Pichlmayr R, Behrend M, Vanrenterghem Y, Donck J, van Hooff J, Christiaans M, Morales JM, Andres A, Johnson RW, Short C, Buchholz B, Rehmert N, Land W, Schleibner S, Forsythe JL, Talbot D, Pohanka E (August 1997). “Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group”. en:Transplantation (journal)64 (3): 436–43. doi:10.1097/00007890-199708150-00012. PMID9275110.
^Liu J, Farmer JD, Lane WS, Friedman J, Weissman I, Schreiber SL (August 1991). “Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes”. Cell66 (4): 807–15. doi:10.1016/0092-8674(91)90124-H. PMID1715244.
^Fegan, A; White, B; Carlson, JC; Wagner, CR (2010 Jun 9). “Chemically controlled protein assembly: techniques and applications.”. en:Chemical Reviews110 (6): 3315–36. PMID20353181.